Discovery, Clinical Development, and Therapeutic Uses of Bisphosphonates
- 1 April 2005
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 39 (4), 668-677
- https://doi.org/10.1345/aph.1e357
Abstract
OBJECTIVE: To review the literature concerning the history, development, and therapeutic uses of bisphosphonates. DATA SOURCES: English-language articles were identified through a search of MEDLINE (through December 2004) using the key word bisphosphonate. Reference lists of pivotal studies, reviews, and full prescribing information for the approved agents were also examined. STUDY SELECTION AND DATA EXTRACTION: Selected studies included those that discussed the discovery and initial applications of bisphosphonates, as well as their historical development, pharmacokinetic and pharmacodynamic properties, and current therapeutic uses. DATA SYNTHESIS: Bisphosphonates structurally resemble pyrophosphates (naturally occurring polyphosphates) and have demonstrated similar physicochemical effects to pyrophosphates. In addition, bisphosphonates reduce bone turnover and resist hydrolysis when administered orally. The information gained from initial work with etidronate generated a considerable scientific effort to design new and more effective bisphosphonates. The PCP moiety in the general bisphosphonate structure is essential for binding to hydroxyapatite and allows for a number of chemical variations by changing the 2 lateral side chains (designated R1 and R2). The R1 side chain determines binding affinity to hydroxyapatite, and the R2 side chain determines antiresorptive potency. Accordingly, each bisphosphonate has its own characteristic profile of activity. CONCLUSIONS: The bisphosphonates reduce bone turnover, increase bone mass, and decrease fracture risk and therefore have a significant place in the management of skeletal disorders including osteoporosis, Paget's disease, bone metastases, osteogenesis imperfecta, and heterotopic ossification.Keywords
This publication has 91 references indexed in Scilit:
- Glucocorticoid-induced osteoporosisEndocrinology and Metabolism Clinics of North America, 2003
- Guidelines on the management of Paget’s disease of bone*Bone, 2002
- Metastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treatment Reviews, 2001
- Comparison of 99mTc-labeled phosphate and phosphonate agents for skeletal imagingSeminars in Nuclear Medicine, 1976
- The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystalsCalcified Tissue International, 1973
- A Review of the Physiological and Pharmacological Effects of Pyrophosphate and Diphosphonates on Bones and TeethJournal of Dental Research, 1972
- Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivoScience, 1969
- The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution of calcium phosphate in vitro and in vivoCalcified Tissue International, 1968
- Isolation from urine of pyrophosphate, a calcification inhibitorAmerican Journal of Physiology-Legacy Content, 1962
- The Inhibiting Action of Minute Amounts of Sodium Hexametaphosphate on the Precipitation of Calcium Carbonate from Ammoniacal Solutions. II. Mechanism of the Process, with Special Reference to the Formation of Calcium Carbonate Crystals.The Journal of Physical Chemistry, 1940